How Decision Rules Rule Out Pulmonary Embolism Without a Scan

How can a doctor rule out a blood clot in the lung without imaging?

Clinical decision rules rule out pulmonary embolism when a structured estimate of risk, combined with a blood test, drives the chance of a missed clot below roughly one to two percent. A clinician scores a small set of findings, sometimes adds a D-dimer result, and if the combination lands in a defined low-risk zone, the guidelines say a CT scan of the chest arteries adds more harm than help. The rules that do this work, Wells, PERC, age-adjusted D-dimer, and YEARS, are not shortcuts. They are the product of studies that followed thousands of untested patients for three months to see how many clots were missed.

That three-month follow-up is the quiet engine behind everything here. A decision rule earns trust only when researchers apply it, withhold imaging from the low-risk group, and then count how many of those people return with a clot. The accepted ceiling for a safe rule is a failure rate under one to two percent, a benchmark drawn from the historical miss rate after a normal pulmonary angiogram. Everything below is an appraisal of how each rule performs against that bar.

The problem the rules are trying to solve

Pulmonary embolism is common enough to fear and vague enough to overtest. Its symptoms, breathlessness, chest pain, a racing heart, overlap with dozens of harmless conditions. So the reflex is to scan, and CT pulmonary angiography is fast and accurate. The trouble is that scanning everyone carries its own cost: radiation, contrast reactions, kidney strain, incidental findings that trigger more tests, and the discovery of tiny clots that may never have caused harm. When most scans come back negative, the yield is low and the collateral damage is real.

Decision rules exist to raise that yield. The goal is not to catch every conceivable clot regardless of cost. It is to identify the patients whose risk is genuinely so low that the expected harm of imaging outweighs the expected benefit, and to do so in a way that can be written down, taught, and audited.

Wells: turning gestalt into a score

The Wells score was the first widely adopted attempt to convert a clinician's judgment into points. It assigns weight to items such as signs of a leg clot, a heart rate over 100, recent surgery or immobilization, prior venous thromboembolism, and, tellingly, whether pulmonary embolism is the most likely diagnosis. That last item bakes clinical intuition directly into the arithmetic.

Wells sorts patients into probability tiers. For those below the threshold, a normal D-dimer, a blood test that rises when the body is breaking down clots, is enough to consider the diagnosis excluded. The value of Wells is that it makes reasoning explicit. Its limit is that D-dimer is a blunt instrument: it climbs with age, pregnancy, infection, cancer, and surgery, so in older or sicker patients a fixed cutoff turns positive constantly and sends nearly everyone to the scanner anyway.

PERC: a rule for ruling out testing itself

The pulmonary embolism rule-out criteria take a different tack. PERC is eight yes-or-no findings: age under 50, pulse under 100, oxygen saturation above 94 percent, no unilateral leg swelling, no blood in the sputum, no recent trauma or surgery, no prior clot, and no estrogen use. If a clinician already judges the risk low and all eight are satisfied, the rule says do not even order a D-dimer. The clot risk is low enough that the test would cause more false alarms than it prevents missed clots.

The strongest evidence for PERC comes from the PROPER randomized trial published in JAMA in 2018. Emergency departments were assigned to a PERC-based strategy or a conventional one, and the three-month rate of a later clot was 0.1 percent with PERC versus 0 percent conventionally, a difference that met the trial's noninferiority margin. That is the kind of result that justifies withholding a test: not zero missed clots, but a miss rate low enough that the imaging avoided is worth it.

Age-adjusted D-dimer: fixing the threshold, not the test

The age-adjusted D-dimer addresses the weakness in the Wells pathway. Instead of a fixed cutoff of 500, it raises the threshold for anyone over 50 to their age multiplied by ten. A 75-year-old is allowed a D-dimer up to 750 before imaging is triggered. The ADJUST-PE study, published in JAMA in 2014, validated this across thousands of patients. Among those sent home without a scan because they fell below the age-adjusted cutoff, the three-month rate of venous thromboembolism was well under one percent, while the adjustment let substantially more older patients avoid imaging than the fixed threshold allowed. It is a small change in a number with a large effect on how many scans happen.

YEARS: fewer questions, a movable line

The YEARS algorithm, validated in a prospective Dutch cohort published in The Lancet in 2017, simplifies the whole sequence. It asks three questions, signs of a leg clot, blood in the sputum, and whether pulmonary embolism is the most likely diagnosis, and then applies a D-dimer threshold that moves depending on the answers. With none of the three present, the cutoff rises to 1000; with any present, it stays at 500. In the validation cohort, this excluded pulmonary embolism without a scan in nearly half of patients, compared with about a third under the older Wells-and-fixed-D-dimer approach, and the failure rate among those managed without imaging stayed near half a percent.

Reading the failure-rate evidence honestly

The appraisal that matters is not which rule is cleverest but whether skipping the scan is safe, and safety here has a precise meaning: the three-month clot rate in the untested group. A pragmatic Australian study published in Emergency Medicine Australasia in 2019 stitched Wells, PERC, and age-adjusted D-dimer into one flowchart and measured what happened in practice. Imaging fell by roughly 40 percent, the share of scans that actually found a clot rose, and no missed clots were traced to the flowchart. That is the pattern each of these rules is built to produce: fewer scans, higher yield, and a miss rate held below the accepted ceiling.

None of this replaces judgment. These rules are validated in adults with suspected pulmonary embolism, not in pregnancy without dedicated pathways, not in people already on blood thinners, and not as a substitute for reconsidering when a patient does not fit the low-risk picture. A rule is a floor for safe reasoning, not a ceiling on it. This article is educational and not medical advice; decisions about testing belong to a clinician who can see the whole patient.